Company Financials: Titan Pharmaceuticals, Inc.

Datamonitor, April 2011

Introduction
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. THIS PRODUCT HAS BEEN DESIGNED FOR DELIVERY IN A DATAPACK FORMAT (.XLS). PLEASE SELECT THE DATAPACK OPTION FROM THE DOWNLOAD MENU.

Scope
Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
Provides key ratios
Includes information on revenue distribution by business segments and geographies

Highlights
Titan Pharmaceuticals (Titan) is a biopharmaceutical company engaged in the development of products for the treatment of central nervous system (CNS) diseases. Titan's out licensed product, Fanapt (iloperidone) is an atypical antipsychotic approved in the US for the treatment of schizophrenia in adult patients.

Reasons to Purchase
Access important financial information and analysis on the company in a single datapack
Understand the financial evolution of the company over the last five years
Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Aerospace and Defense Industry - Global Strategic Business Report
• Sports and Fitness Nutrition - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Global UAV Payload Market 2012-2022
• Private Tutoring - Global Strategic Business Report
• Defense Robotics - Global Strategic Business Report